Oct 16, 03
|
| 19:10 ET |
Allergan Announces Agreement to Acquire Oculex Pharmaceuticals, Inc.
|
|
May 08, 03
|
| 08:16 ET |
Oculex Announces Positive Clinical Results for Posurdex(R) - The First Biodegradable Ocular Implant in Clinical Trial
|
|
Apr 03, 03
|
| 07:31 ET |
Oculex Pharmaceuticals to Announce Preliminary Phase 2 Efficacy and Safety Results for Posurdex(R) at ARVO
|
|
Mar 31, 03
|
| 07:31 ET |
Oculex Pharmaceuticals to Present at the BioCentury 'Future Leaders in the Biotech Industry' Conference
|
|
Dec 04, 02
|
| 13:17 ET |
Oculex Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Trial For Persistent Macular Edema Treatment
|
|
Oct 22, 02
|
| 09:06 ET |
Oculex Pharmaceuticals Raises $50 Million Through Private Financing
|
|
Oct 29, 01
|
| 07:31 ET |
Oculex Pharmaceuticals Begins Phase II Clinical Trial of Posurdex For Persistent Macular Edema
|
|
May 21, 01
|
| 16:38 ET |
Allergan and Oculex Enter Into Collaboration for Novel Drug Delivery Technology in the Back-of-the-Eye Ophthalmic Arena
|
|
Jan 19, 01
|
| 14:38 ET |
Oculex Pharmaceuticals Adds Stanford Chairman of Ophthalmology To Board of Directors
|
|
Jan 31, 00
|
| 16:14 ET |
Oculex Pharmaceuticals to Formulate Allergan Compounds Using DDS(R) Technology
|
|
|